Atarax (Hydroxyzine Hydrochloride) - Side Effects and Adverse Reactions

ADVERSE REACTIONS

Side effects reported with the administration of Atarax (hydroxyzine hydrochloride) are usually mild and transitory in nature.

Anticholinergic

Dry mouth.

Central Nervous System

Drowsiness is usually transitory and may disappear in a few days of continued therapy or upon reduction of the dose. Involuntary motor activity including rare instances of tremor and convulsions have been reported, usually with doses considerably higher than those recommended. Clinically significant respiratory depression has not been reported at recommended doses.

REPORTS OF SUSPECTED ATARAX SIDE EFFECTS / ADVERSE REACTIONS

Possible Atarax side effects / adverse reactions in 54 year old female

Reported by a physician from France on 2011-10-04

Patient: 54 year old female

Reactions: Ocular Hypertension

Suspect drug(s):
Atarax

Possible Atarax side effects / adverse reactions in 46 year old male

Reported by a physician from France on 2011-10-08

Patient: 46 year old male

Reactions: Eosinophil Count Increased, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Suspect drug(s):
Atarax
    Administration route: Oral
    Indication: Anxiety
    Start date: 2011-08-30
    End date: 2011-08-30

Ibuprofen
    Administration route: Oral
    Indication: Musculoskeletal Pain
    Start date: 2011-08-25
    End date: 2011-08-30

Iopamidol
    Indication: Musculoskeletal Pain
    Start date: 2011-08-31
    End date: 2011-08-31

Xylocaine
    Indication: Musculoskeletal Pain
    Start date: 2011-08-31
    End date: 2011-08-31

Hexatrione
    Indication: Musculoskeletal Pain
    Start date: 2011-08-31
    End date: 2011-08-31

Omeprazole
    Administration route: Oral
    Indication: Gastritis Prophylaxis
    Start date: 2011-08-25
    End date: 2011-08-30

Possible Atarax side effects / adverse reactions in 48 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-11

Patient: 48 year old male

Reactions: OFF Label USE, Dyspnoea, Condition Aggravated, Leukocytosis, Rash Maculo-Papular, Myeloproliferative Disorder, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Suspect drug(s):
Desloratadine
    Dosage: po
    Administration route: Oral
    Indication: Rash Maculo-Papular
    Start date: 2011-08-09
    End date: 2011-08-19

Atarax
    Dosage: po
    Administration route: Oral
    Indication: Rash Maculo-Papular
    Start date: 2011-08-09
    End date: 2011-08-19

Fucidine CAP
    Dosage: 500 mg; bid; po
    Administration route: Oral
    Indication: Eczema Weeping
    Start date: 2011-08-09
    End date: 2011-08-15

Nerisone
    Dosage: top
    Administration route: Topical
    Indication: Eczema Weeping
    Start date: 2011-08-09
    End date: 2011-08-19